MargaretAKurthMD

Pediatric Hematology & Oncology • Minneapolis, MN

Physician

Join to view full profile

Dr. Kurth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kurth's full profile

Already have an account?

Office
2525 Chicago Avenue South
Childrens Specialty Clinic Hematology Oncology Mpls
Minneapolis, MN 55404
Phone+1 612-813-5940

Fax+1 612-813-6325
Is this information wrong?

Education & Training

Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1979 - 1982
University of MinnesotaResidency, Pediatrics, 1976 - 1978
University of Minnesota Medical SchoolClass of 1976

Certifications & Licensure

CA State Medical License 1979 - Present
MN State Medical License 1977 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

5 citations
Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors.
Víctor Jiménez-Yuste, Johannes Oldenburg, Savita Rangarajan, Margaret Heisel Kurth, J. Bozzo, Elena Santagostino> ;Haemophilia. 2016 Jan 1
25 citations
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
Rachael F. Grace, Carolyn M. Bennett, A. Kim Ritchey, Michael Jeng, Courtney D. Thornburg, Michele P. Lambert, Michelle Neier, Michael Recht, Manjusha Kumar, Victor Bl...> ;Pediatric Blood & Cancer. 2012 Feb 1
40 citations
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: The US experience
M. Kurth, J. Puetz, Peter A. Kouides, J. Sanders, C. Sexauer, J. Bernstein, Ralph A. Gruppo, Marilyn J. Manco-Johnson, Ellis J. Neufeld, Nidra I Rodriguez, Brian M. Wi...> ;Journal of Thrombosis and Haemostasis. 2011 Nov 1
4 citations
von Willebrand factor: what is its role in the immune response in haemophilia?
Srini V. Kaveri, P. M. Mannucci, Margaret Heisel Kurth, Nadia P. Ewing, Craig M. Kessler, Diane J. Nugent, Edward D. Gomperts> ;Haemophilia. 2011 Jan 1
10 citations
Treatment and outcomes for epistaxis in children with Glanzmann's thrombasthenia
R. Raul Rosas, Margaret Heisel Kurth, James D. Sidman> ;The Laryngoscope. 2010 Dec 1
16 citations
Intracranial hemorrhage in newborns with hemophilia: The role of screening radiologic studies in the first 7 days of life
Angela R. Smith, Nicole Leonard, Margaret Heisel Kurth> ;Journal of Pediatric Hematology/oncology. 2008 Jan 1
45 citations
Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
Margaret Heisel Kurth, Donna DiMichele, C. Sexauer, J. Sanders, M. Torres, S. C. Zappa, M. V. Ragni, N. Leonard> ;Haemophilia. 2007 Oct 18
Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome.
Smith, A. R., Hennessy, J. M., Kurth, M. A., Nelson, S. C.> ;Pediatr Blood Cancer. 2008 Sep
Join now to see all